ImmunoCellular (IMUC) +7% AH after announcing Andrew Gengos, until recently the CEO of private...

|About: ImmunoCellular Therapeutics... (IMUC)|By:, SA News Editor

ImmunoCellular (IMUC) +7% AH after announcing Andrew Gengos, until recently the CEO of private Neuraltus Pharmaceuticals, is its new CEO. Chief scientific officer John Yu had been serving as interim CEO since August, when former chief Manish Singh stepped down.